What side effects are associated with this type of intervention?

Behavioral interventions for alcohol use disorder, such as cognitive-behavioral therapy (CBT) and motivational interviewing, typically have minimal side effects but may cause emotional discomfort as patients address their behaviors and thoughts. For chronic pain, interventional therapies like steroid injections and nerve blocks can cause temporary pain at the injection site, infection, and rarely, nerve damage. Internet-based videoconferencing for these treatments may introduce technical issues and reduced personal interaction, potentially impacting treatment effectiveness.

What prior FDA approvals exist?

The FDA has approved several pharmacologic treatments for alcohol use disorder, including naltrexone, acamprosate, and disulfiram. For chronic pain, FDA-approved medications include acetaminophen, NSAIDs, certain antidepressants, and anticonvulsants. Behavioral therapies, such as cognitive-behavioral therapy (CBT) and motivational interviewing, have also been effective for both conditions. Recent advancements include the use of technology-enhanced delivery methods, such as internet-based videoconferencing, to provide these behavioral interventions, which align with the integrated behavioral approach being studied.

What other types of research exist?

Promising novel alternatives for treating alcohol use and chronic pain include: 1) Digital Cognitive Behavioral Therapy (CBT) for Insomnia (CBT-I), which has shown efficacy in improving sleep-related quality of life and reducing insomnia symptoms, potentially benefiting patients with comorbid conditions. 2) Telehealth-based delivery of CBT, which has been effective in various settings and can overcome barriers related to travel and access to treatment sites. 3) Motivational Interviewing (MI), which has been effective in substance use disorders and can be delivered via web-based platforms. 4) Behavioral Medical Management, a structured intervention that supports medication adherence and monitors substance use, which can be integrated with telehealth services.

← Back to Search

Online Counseling for Chronic Pain and Alcohol Use

N/A

Waitlist Available

Research Sponsored by Boston University Charles River Campus

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial will test a new way to help HIV patients who drink too much and have chronic pain, by talking to them over the internet.

Who is the study for?

This trial is for HIV-care patients who drink heavily (more than 7/14 drinks per week for women/men) and have chronic non-cancer pain lasting at least 3 months. It's not suitable for those with upcoming surgeries, on short-term psychoactive meds, or with bipolar disorder, schizophrenia, suicidal intent, a history of severe alcohol withdrawal symptoms, or current treatment for pain or alcohol use.Check my eligibility

What is being tested?

The study tests an integrated behavioral approach to reduce heavy drinking and chronic pain via internet-based videoconferencing. Participants will either continue their usual care or receive the Motivational and Cognitive-Behavioral Management program designed specifically for Alcohol and Pain (MCBMAP).See study design

What are the potential side effects?

Since this is a behavioral intervention involving motivational talks and cognitive-behavioral therapy through video calls rather than medication, typical drug side effects are not expected. However, participants may experience emotional discomfort discussing sensitive topics.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Alcohol Time Line Follow-Back (30) - Average Drinks per Week

Alcohol Time Line Follow-Back (30)- Heavy Drinking Episodes

Brief Pain Inventory - Pain Interference

+1 more

Secondary outcome measures

Goal Systems Assessment Battery-Alcohol

Goal Systems Assessment Battery-Pain

Short Inventory of Alcohol Problems-Revised

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Videoconferencing Intervention for Heavy Drinking and Chronic Pain

Group II: ControlActive Control1 Intervention

Treatment as Usual

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP)

2020

N/A

~50

Do I qualify?Apply below to find out

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

Behavioral interventions for alcohol drinking and chronic pain, such as those delivered via internet-based videoconferencing, typically involve cognitive-behavioral therapy (CBT) techniques. These techniques aim to modify maladaptive thoughts and behaviors related to substance use and pain management. By identifying high-risk situations, teaching coping strategies, and providing continuous support, these interventions help patients reduce alcohol consumption and manage chronic pain more effectively. The use of internet-based videoconferencing makes these treatments accessible and convenient, which is crucial for patients who may have mobility issues or live in remote areas. This approach ensures consistent follow-up and support, which can lead to better adherence and outcomes.

A Process Evaluation of a Substance Use Brief Intervention for Adolescents in a Psychiatric Inpatient Program.Variance in the Efficacy of Brief Interventions to Reduce Hazardous and Harmful Alcohol Consumption Between Injury and Noninjury Patients in Emergency Departments: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Find a Location

Who is running the clinical trial?

Boston University Charles River CampusLead Sponsor

114 Previous Clinical Trials

12,241 Total Patients Enrolled

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH

811 Previous Clinical Trials

1,158,238 Total Patients Enrolled

Media Library

Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP) Clinical Trial Eligibility Overview. Trial Name: NCT04441593 — N/A

Alcohol Drinking and Chronic Pain Intervention Research Study Groups: Control, Intervention

Alcohol Drinking and Chronic Pain Intervention Clinical Trial 2023: Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP) Highlights & Side Effects. Trial Name: NCT04441593 — N/A

Motivational and Cognitive-Behavioral Management for Alcohol and Pain (MCBMAP) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04441593 — N/A

~11 spots leftby Jun 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.